Explore more publications!
Healthy Living Maldives
Got News to Share?

Healthy Living Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 3, 2025

Global Preclinical Imaging Market Set to Reach USD 5.101 Million by 2029 | MarketsandMarkets™
October 3, 2025

Global Preclinical Imaging Market Set to Reach USD 5.101 Million by 2029 | MarketsandMarkets™

Indeterminate GlobeNewswire
Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
October 3, 2025

Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025

Indeterminate GlobeNewswire
Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 3, 2025

Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Indeterminate GlobeNewswire
Candel Therapeutics to Present at the SITC 2025 Annual Meeting
October 3, 2025

Candel Therapeutics to Present at the SITC 2025 Annual Meeting

Indeterminate GlobeNewswire
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 3, 2025

ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Indeterminate GlobeNewswire
Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting
October 3, 2025

Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting

Indeterminate GlobeNewswire
Enara Bio to Reveal DARKFOX, a Novel Cancer-Specific Dark Antigen with Broad-Ranging Therapeutic Potential, in Oral Presentation at SITC 2025
October 3, 2025

Enara Bio to Reveal DARKFOX, a Novel Cancer-Specific Dark Antigen with Broad-Ranging Therapeutic Potential, in Oral Presentation at SITC 2025

Indeterminate GlobeNewswire
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
October 3, 2025

Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

Indeterminate GlobeNewswire
Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
October 3, 2025

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Indeterminate GlobeNewswire
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025
October 3, 2025

BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025

Indeterminate GlobeNewswire
New Jersey Unites Against a Crisis: Knock Out Opioid Abuse Day Set for October 6
October 3, 2025

New Jersey Unites Against a Crisis: Knock Out Opioid Abuse Day Set for October 6

Indeterminate GlobeNewswire
Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off
October 3, 2025

Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off

Indeterminate GlobeNewswire
BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting
October 3, 2025

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

Indeterminate GlobeNewswire
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 3, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Cartesian Therapeutics Announces New Employment Inducement Grant
October 3, 2025

Cartesian Therapeutics Announces New Employment Inducement Grant

Indeterminate GlobeNewswire
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
October 3, 2025

Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds

Indeterminate GlobeNewswire
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
October 3, 2025

Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile

Indeterminate GlobeNewswire
Angelini Ventures Leads €12 Million Follow-On Investment in Serenis, a Fast-Growing Digital Mental and Physical Health Company
October 3, 2025

Angelini Ventures Leads €12 Million Follow-On Investment in Serenis, a Fast-Growing Digital Mental and Physical Health Company

Indeterminate GlobeNewswire
Appointment of Marc Le Bozec as Interim CEO
October 3, 2025

Appointment of Marc Le Bozec as Interim CEO

Indeterminate GlobeNewswire
Nomination de Marc Le Bozec comme Directeur Général par interim
October 3, 2025

Nomination de Marc Le Bozec comme Directeur Général par interim

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions